Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSealand Cap Regulatory News (SCGL)

  • This share is currently suspended. It was suspended at a price of 0.25

Share Price Information for Sealand Cap (SCGL)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £16.37m
SCGL Live PriceLast checked at - London Stock Exchange

Intraday Sealand Cap Share Chart

Total Voting Rights

28 Feb 2025 07:00

RNS Number : 4076Y
Sealand Capital Galaxy Limited
28 February 2025
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED WHICH, BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, FORMS PART OF UK LAW. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE ("RIS"), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

28 February 2025

 

 

Sealand Capital Galaxy Limited

 

("Sealand" or the "Company")

 

TOTAL VOTING RIGHTS

 

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, Sealand Capital Galaxy Limited [LSE: SCGL] ("Sealand" or the "Company") announces that, as of 28 February 2025, the Company's total issued share capital consists of 866,905,989 ordinary shares, with one voting right per share.

 

The total number of voting rights in the Company is therefore 866,905,989.

 

This figure of 866,905,989 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended).

 

 

-Ends-

 

Enquiries:

 

Sealand Capital Galaxy Limited

Dr. Thomas Sawyer (Chief Executive Officer)

Ms. Elena Law (Chairwoman)

Mr. Geoffrey Griggs (Non-Executive Director)

 

Bowsprit Partners Limited (Financial Adviser) +44 (0) 203 833 4430

 

StockBox Media (IR/PR)

Info@Stockmedia.com

 

 

Notes to Editors:

The Company's shares are traded on the transition category of the London Stock Exchange under the ticker SCGL.

 

Further information on Sealand Capital Galaxy Limited is available on its website www.sealandcapitalgalaxy.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRFLFLFFLIEFIE
Date   Source Headline
31st Mar 202212:36 pmRNSTotal Voting Rights
30th Mar 20223:30 pmRNSIssue of New Ordinary Shares
9th Nov 20217:00 amRNSNew brand engagement and brand station launch
21st Oct 20217:00 amRNSIssue of Equity and Grant of Options
11th Oct 20217:00 amRNSLaunch of Heath London Tmall Global Flagship store
4th Oct 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSExclusive Distribution Contracts Update
9th Aug 20217:00 amRNSContract
23rd Jul 20217:00 amRNSDistribution Contracts Signed
19th Jul 202112:44 pmRNSIssue of Equity
13th Jul 202111:37 amRNSLaunch of Online Store - replacement
13th Jul 20217:00 amRNSLaunch of Online Store
30th Jun 202111:56 amRNSPublication of Annual Report
21st May 20217:00 amRNSExtension to Annual R&A publication date
7th May 20217:00 amRNSDistribution Contracts
23rd Apr 20217:00 amRNSNew Contract Win
31st Mar 20217:00 amRNSSubscription, Update, Director Dealing and Change
22nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
22nd Mar 20214:35 pmRNSPrice Monitoring Extension
22nd Mar 20212:06 pmRNSSecond Price Monitoring Extn
22nd Mar 20212:01 pmRNSPrice Monitoring Extension
22nd Mar 202111:05 amRNSSecond Price Monitoring Extn
22nd Mar 202111:00 amRNSPrice Monitoring Extension
22nd Mar 20219:05 amRNSSecond Price Monitoring Extn
22nd Mar 20219:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
1st Mar 20212:06 pmRNSSecond Price Monitoring Extn
1st Mar 20212:00 pmRNSPrice Monitoring Extension
30th Nov 20207:00 amRNSMarket Update
6th Nov 20207:00 amRNSMarket Update: New Contract Win and Partnership
29th Oct 20207:00 amRNSHalf-year Report
6th Oct 20208:00 amRNSAppointment of Adviser
1st Sep 20207:00 amRNSMarket Update
24th Aug 20207:00 amRNSApplication for Placing of Shares
17th Aug 20207:00 amRNSExercise of Warrant & Issue of Equity
20th Jul 20207:00 amRNSNew Contract Win
6th Jul 20207:00 amRNSRestructuring of ePurse and formation of new JVs
1st Jul 20204:35 pmRNSPrice Monitoring Extension
26th Jun 20204:40 pmRNSSecond Price Monitoring Extn
26th Jun 20204:35 pmRNSPrice Monitoring Extension
26th Jun 20202:06 pmRNSSecond Price Monitoring Extn
26th Jun 20202:00 pmRNSPrice Monitoring Extension
26th Jun 202011:05 amRNSSecond Price Monitoring Extn
26th Jun 202011:00 amRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSFormation of new Joint Venture
17th Jun 20207:00 amRNSMarket Update
5th Jun 20207:00 amRNSPublication of Annual Report
19th Nov 20197:00 amRNSAppointment of Broker
14th Oct 20197:00 amRNSFORMATION OF NEW JV AND UPDATE ON SUNCITY CONTRACT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.